Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model

Schwander, Björn; Gradl, Birgit; Zöllner, York; Lindgren, Peter; Diener, Hans-Christoph; Lüders, Stephan; Schrader, Joachim; Villar, Fernando Antoñanzas; Greiner, Wolfgang; Jönsson, Bengt

doi:10.1111/j.1524-4733.2009.00507.x

Publisher DOI:	10.1111/j.1524-4733.2009.00507.x
Title:	Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model
Language:	English
Authors:	Schwander, Björn Gradl, Birgit Zöllner, York Lindgren, Peter Diener, Hans-Christoph Lüders, Stephan Schrader, Joachim Villar, Fernando Antoñanzas Greiner, Wolfgang Jönsson, Bengt
Issue Date:	2009
Journal or Series Name:	Value in health : the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Volume:	12
Issue:	6
Startpage:	857
Endpage:	871
URI:	http://hdl.handle.net/20.500.12738/2979
Review status:	This version was peer reviewed (peer review)
Institute:	Fakultät Life Sciences Department Gesundheitswissenschaften
Type:	Article
Appears in Collections:	Publications without full text